Device interaction between cardiac contractility modulation (CCM) and subcutaneous defibrillator (S-ICD).

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Cardiac contractility modulation (CCM) and subcutaneous implantable cardioverter-defibrillators (S-ICDs) are advanced therapies for heart conditions.
• Combined implantation aims to reduce lead-related complications and improve patient outcomes.

Observation:

• A patient with ischemic cardiomyopathy received a CCM device alongside an existing S-ICD.
• Post-implantation crosstalk testing revealed S-ICD misinterpretation of cardiac signals (QRS and T waves).

Findings:

• Device interference was successfully resolved by reprogramming the CCM device.
• The S-ICD maintained its therapeutic functionality without compromise.
• The patient experienced improved heart failure symptoms post-intervention.

Implications:

• Combined CCM and S-ICD therapy is a potentially safe and effective strategy for managing heart failure and arrhythmias.
• Careful device programming and crosstalk assessment are crucial for successful co-implantation.
• This approach may offer a lead-sparing alternative for select patient populations.